A challenge for the development of malaria vaccines: polymorphic target antigens
- PMID: 17388671
- PMCID: PMC1820606
- DOI: 10.1371/journal.pmed.0040116
A challenge for the development of malaria vaccines: polymorphic target antigens
Erratum in
- PLoS Med. 2007 May;4(5):e175
Conflict of interest statement
Comment on
-
Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.PLoS Med. 2007 Mar;4(3):e93. doi: 10.1371/journal.pmed.0040093. PLoS Med. 2007. PMID: 17355170 Free PMC article.
References
-
- Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: Single-blind extended follow-up of a randomised controlled trial. Lancet. 2005;366:2012–2018. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
